Orthofix国际 OFIX 深 沪
已收盘 08-22 16:00:00 美东时间
14.55
0.000
0.00%
华盛通- 最 高15.075
- 今 开14.70
- 成交量 43.21万股
- 最 低 14.52
- 昨 收 14.55
- 总市值 5.70亿
- 52周最高 20.7299
- 市盈率 静 --
- 换手率 1.10%
- 52周最低 10.24
- 委 比 -61.82%
- 总股本 3918.08万
- 历史最高 74.44
- 量 比 0.90
- 振 幅 3.81%
- 历史最低 9.575
- 每 手 1
- 风险率 1.73%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage
Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a $16 target.
08-19 02:25
Orthofix Medical shares are trading higher after the company reported better-than-expected Q2 financial results.
Orthofix Medical shares are trading higher after the company reported better-th...
08-05 23:54
Orthofix anticipates full-year net sales of $808M–$816M while accelerating U.S. spine distributor transition
Earnings Call Insights: Orthofix Medical Inc. (OFIX) Q2 2025 Management View President and CEO Massimo Calafiore stated the company achieved second quarter pro forma net sales of $200.7 million, marki...
08-05 23:18
Orthofix Medical Affirms FY2025 Sales Guidance of $808.000M-$816.000M vs $812.800M Est
Orthofix Medical (NASDAQ:OFIX) affirms FY2025 sales outlook from $808.000 million-$816.000 million to $808.000 million-$816.000 million vs $812.800 million estimate.
08-05 19:09
Orthofix Medical Q2 Adj. EPS $0.13 Beats $(0.49) Estimate, Sales $203.121M Beat $196.890M Estimate
Orthofix Medical (NASDAQ:OFIX) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $(0.49) by 126.53 percent. This is a 160 percent increase over earnings of $0.05 per share from
08-05 19:04
Earnings Scheduled For August 5, 2025
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
Semler Scientific's Earnings Outlook
Semler Scientific (NASDAQ:SMLR) is preparing to release its quarterly earnings ...
08-02 04:04
OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System and Completes First Case
OrthoPediatrics Corp. announced the US launch of its new 3P™ Pediatric Plating Platform™ Hip System, designed to treat proximal femur fractures and deformities in children. The system features advanced implant and instrument technology, offering improved precision and fixation options for both trauma and deformity surgeries. Over 10 cases were booked shortly after the launch, with significant growth expected. The company emphasized its commitment...
08-01 12:05
Butterfly Network's Earnings Outlook
Butterfly Network (NYSE:BFLY) is preparing to release its quarterly earnings on...
08-01 02:01
Global POISE Study Reaches Milestone of 600 Orthopedic Implants in Pediatric Patients, Advancing Research on the Safety and Efficacy of OrthoPediatrics® Products
OrthoPediatrics Corp. announced a significant milestone in its Global POISE Study, with over 600 implants being observed across 300+ pediatric patients. Launched in 2023, the multi-center, post-market study aims to assess the safety and efficacy of OrthoPediatrics' implant devices. Currently, 13 active sites in Canada, the U.S., Australia, New Zealand, and South Africa are participating. The study's insights will help refine devices for children ...
07-16 11:00
